I remember now when you tried that here a while back; but maybe because it wasn't a group effort - that it wasn not considered On Topic. The On Topic dicussions are not only supposed to be BIEL
centered, but what the TOS allows: i.e: only mentioning names of people who work for BIEL are allowed and it's distributors, language used, etc. But competitors should be allowed also to be mentioned - as they can pertain to BIEL, just be careful on the wording and content I guess.

With "A theory that has yet to materialize." There are still plenty of bielievers here that have enough hope that certain things will "materialize" for us, and thereby eventually will produce the substance, or the evidence that you do not see 'materialized' at the moment. (And since this isn't Star Trek we can't just transport (beam over) the head of the FDA to get a decision.

What makes no sense to me is that even though Allay was denied, that denial was appealed, and since that appeal process began, (which you practically deny it's existence), the FDA has yet to re-issue the same answer as before. Therefore, If the FDA was so certain of their original denial, then why the wait well beyond (30) days to respond, even with the power outage its been over (30) days and that makes no sense at all to me.....Unless the FDA was uncertain of their first decision after the meeting of the knowledgable minds, then they will be very cautious this time. It's quite obvious that the Allay 'denial' is not so carved-in-stone as you portray now is it!

My money is on the PhD from MIT! Unless you can meet or beat those credentials - all others should and will be ignored. IMO. Let's Go FDA ! GO BIEL!!!!!!

Right investorsciple! and I remember showing my math in post #21831 after kidnova brought it to our attention:
"You are right kidnova; I get a 66.9% decrease. 124,159 - 375,436 = -251,277/375,436= -0.669 x 100% = (-66.9%)"

Just have to wait for a while! That's what can happen when a pps doesn't move for a while; esp. if you're shorting it. You just have to wait. Time is money though. Then again it may go up again real soon and this could be the calm before the storm. . . .

Last I heard we were waiting mainly for FDA approvals. Gee, it looks like that's an extremely difficult concept apparently. LOL

This is the year for BIEL! IMO They are in the FDA's radar and the FDA will be forced to answer one way or another - as their so-called timeline is running out! Senators and the Inspector General is aware and now the FDA will have to have an answer that is either acceptable or that will refute a PhD from MIT. Any further stalling from the FDA should be investigated thoroughly at this point.

9-18-2006?? Really?? But let's not forget what happened to the market as some continue to glance backward - into the past. Since 2006, there was a severe market crash taking out huge companies and many of them have now fleeced America from the virtually forced bailouts for the 'too big to fail' bunch. It's kind of a miracle that Bioelectronics Corporation has survived one of the harshest financial environments in existence for some time now without any bailouts from the taxpayers. As far as I am concerned, no matter what happens, BIEL has already done well to survive this far and has plenty more steam left. IMO

Thanks UK. (It's gotta be days - well there are 365 days in a year - lol)

Could be wrong, but I don't thInk Bones was responding to you, but to CMK.

This is why OTC approval in the U.S. right now is critical. Then the company can begin to really advertise here as well as abroad (at reduced cost due to currency exchange rates). Also, can you imagine a health care system here that dictates every drug or 'device' that only the government would allow coverage for? Sounds potentially dangerous to me.

Wow gman! With 14 mil. you can have a spot on The BOD and a seat on the eventual BIEL helicopter.

V V.                       V V
  V V.                   V V
    V V.                V V
      V V.            V V
        V V.         V V
          V V.    V V
            V V. V V.    I C T O R Y !!!

Just getting ready for our FDA VICTORY - Coming soon
to shareholders near you ----- from your friendly neighborhood
BIEL Investor.

Another sign that things may be turning, a huge payout from Big Parma recently:
GlaxoSmithKline Pays $3B to Settle DOJ's Fraud Case

http://legaltimes.typepad.com/blt/2012/07/glaxosmithkline-agrees-to-3b-settlement-with-doj.html

See post #23365; I believe that's the post we read....this past Wednesday.

I read that post you are referring to - so it exists but I don't know by whom or when that was posted either.

I agree Frodo, I'm hoping to hear by this Friday!!

I don't know what it is; but all this talk about Bioelectronics Corporation just makes me want to buy more shares . . . . how about you? You in? Hurry, while there's still time! I got two words for you: Rx Recovery!

Very interesting speakhim; thanks for sharing.

Keep in mind that the company has sold around $5 mil. since inception.
____________________________________________________________
That statement reminded me of a burger joint that started years ago, when it
had sold 5 million burgers and they proudly displayed it on their sign. Well that
was when it was a Startup and you could even buy the franchise. Now they
have reached hundreds of billions sold and dont bother to display the total count
anymore. BIEL is a startup and have sold over 5 million dollars of product so far
and that is probably because it is just starting to make it's way. Extra ketchup
Please?....

Good start this week so far! Totally unlike the predicted doom & gloom! LOL

Gold ducats were struck in 980 fine gold. Maybe the MMs believe and are communicating that there is a potential gold strike coming soon here??!!!

I'm not sure what you want us to say to the FDA, but I just called one of their numbers: 1-888-INFO-FDA (1-888-463-6332); and and I asked them directly when I could once again purchase Bioelectronics Corporations Actipatch from the Canadian website to be shipped into the United States and the woman on the other end said that was probably because of the letter they sent to them (BIEL) (so she was aware of the letter?) and since she could not discuss anything due to pending decisions, that I should contact the company. (Her response was exactly what was expected).

Right, and the BIEL RxRecovery product is up to (10) times stronger than any other Bioelectronics PEMF product, and was approved already by the FDA for prescription after surgery use (right next to the brain!) ZERO side affects!! How the FDA can not see their own folly is beyond many people's understanding.

Yes, inevitable!

Nicely put. (I would love to see the minutes on that meeting on June 8th with the FDA).

"there is no point is approving a product when it is obvious, economicaly speaking, that it would never get to market."
Ok, but what happens when the FDA gets behind on its evaluation process and takes so long that a real small but capable company like Bioelectronics Corporation is forced to wait soooo long for an FDA decision that it exhausts much of its financial resources in a very difficult economy, yet has proven on a few second spot on Dr. Oz that BIEL can sell product in the U.S., but now are still forced to wait while the FDA, who sent a letter to stop sales in the mean time (until the FDA takes a few more years to decide!??) This is what is ludicrous about this somewhat fascist style device approval system. I'm not the only person here who can see this!! Defend the FDA all you like - because though it's sad to say - it is the only game in town.....

I agree investordisciple. There's a lot of great info here that should be stickied (updated) in the ibox. One of my favorite parts is the one about FDA Allay and the BIEL consultants representing them at the FDA meeting on June 8th. Even bashers must shamefully admit that their credentials couldn't be any better to represent BIEL. IMO.
"We were pleased with the Friday, June 8, meeting with the FDA. At the meeting we addressed the application of the technology to support our menstrual pain medical claim for Allay.
Dr. Kenneth McLeod, our consulting biophysics expert, made the technical presentation. Dr. McLeod received his PhD from MIT in electrical engineering, with a dissertation focused on electrophysiological properties of living tissue, and has worked in the field of bioelectromagnetics for more than 30 years. He is currently Director of the Clinical Science and Engineering Research Center at Binghamton University where the research is largely focused on functional disorders (such as chronic pain) and interventions to address these disorders. BioElectronics’ Chairman, Dr. Richard Staelin, is a mathematician and statistician, and was in attendance to support the clinical data analysis. Andrew Whelan was also in attendance at the meeting."

Nice - Danzo!

Perhaps for those of you that think I am making this up about the drug companies and the FDA, then listen to Marcia Angell, MD's "The Truth about Drug Companies." Get an "eye" opening perspective for a change:

Dearest ddls, Your case is weakening; I guess we have another credible witness, Rohit Chohan, who is the Head of Medical Devices of Juno Pharmaceuticals, along with Indian medical professionals to add to our list of Bioelectronics Corporation supporters: "According to Rohit Chohan, Head – Medical Devices of Juno Pharmaceuticals, "We are planning an aggressive marketing campaign to reach the many Indian consumers dealing with unresolved pain issues. Indian medical professionals who have tried the product echo the positive testimonials we've seen from around the world." Also important to BIEL's cause: Juno Pharmaceuticals is planning an "Aggressive marketing campaign." I have not heard any such things from Greenwood???? If this aggressive marketing campaign gets good results, they should pass it expeditiously on to Greenwood. IMO (It looks like the Indian drug cartel does not feel the same as the American drug cartel when it comes to alternative pain solutions).

No. And as much as I want Bioelectronics Corporation to be able to sell in the U.S., I still want for it to be done through the system that has been legally set up here in the U.S. - ironic as that is - else we'd be no better than the thugs that are going out of their way to prevent new products like what BIEL offers and who are interfering with potentially valid cures that many people will never see because of being suppressed - and by funds being cut off once researchers get too close. I guess they want people to use the OTC pet patches in the mean time because the FDA has gone to the dogs! IMO.

News for 'BIEL' - (BioElectronics Corporation Announces Indian Distributor's Ecommerce  Website Juno Pharmaceuticals Launches ActiPatch® Website --)
   

FREDERICK, Md., June 21, 2012 /PRNewswire via COMTEX/ -- BioElectronics Corp.
(OTC-PINK: BIEL), the maker of inexpensive, disposable drug-free
anti-inflammatory devices, today announced that its Indian distributor, Juno
Pharmaceuticals, has launched an Ecommerce website at http://www.actipatch.in
which will be accepting orders for BIEL's ActiPatch® pain relief device for
India's 1.2 billion consumers.

According to Rohit Chohan, Head - Medical Devices of Juno Pharmaceuticals, "We
are planning an aggressive marketing campaign to reach the many Indian consumers
dealing with unresolved pain issues. Indian medical professionals who have tried
the product echo the positive testimonials we've seen from around the world."

According to the Associated Chambers of Commerce and Industry of India, the
Indian online retail industry is expected to grow by 35 percent annually to
touch 70 billion rupees ($1.4 billion) by 2015, up from 20 billion rupees now.

"We are pleased to be working with such an aggressive young company to bring
ActiPatch's proven relief to consumers in India," said Andrew Whelan, CEO and
president, BioElectronics Corp.

BIEL's ActiPatch® products -- which can be used for back, knee, wrist, elbow,
heel and other pain, at less cost than over the counter medication and with no
side effects - shut down the body's inflammation, push fluid out of the swollen
tissue and accelerate healing even in chronic wounds.

About Juno Pharmaceuticals

Juno Pharmaceuticals - Medical Division is aimed at becoming an exclusive
service provider to healthcare industry with marketing, distribution, logistics
support for high technology drugs/devices/equipments and specialized services in
niche segments of healthcare, in order to improve patient health at affordable
cost with highest quality standards. Juno is funded and backed by a Canadian
venture fund developed and funded by experienced pharmaceutical executives. The
company is committed to bringing reliable, long-lasting and quality products
from world over to cater the medical specialists, Institutions, distributors and
associations.

For media enquiries, please contact:

Rohit Chohan

Juno Pharmaceuticals

rohitchohan@junopharm.com

Phone: +91-9177-999-600

About BioElectronics CorporationBioElectronics is an award winning developer and
manufacturer of advanced medical devices. Its products are ActiPatch® Therapy,
for over-the-counter treatment of back pain and other musculoskeletal ailments,
the Allay(TM) Menstrual Cycle Pain Therapy, and RecoveryRx(TM) for surgical
procedures and wound care. The unique therapy delivery system, using patented
technology, provides a cost-effective home care to reduce soft tissue pain and
swelling. For more information, please see www.bielcorp.com.

Contact: E & E CommunicationsPaul Knopick(949) 707-5365

SOURCE BioElectronics Corp.



www.prnewswire.com


Copyright (C) 2012 PR Newswire.

Duely noted Ghost - both posts. It's amazing the stuff that sounds believable. That other poster has lost all credibility with me. Thanks Paul for clearing that up.

Threepointer, I understand what you are saying, but you do realize that this can't and won't go on forever and yes many of us have been waiting for years. Each passing day, week, and month that passes without some kind of sales launch or FDA breakthrough means that BIEL gets closer and closer to the end of it's funds when they are no longer able to unload shares to a bidder. This is exactly, I believe, what BIEL's competitors want. Lets not forget that BIEL's competitors also include any company that has a pain patch of one form or another, not just pain pills. If only BIEL could sell patches to foreigners like they are able to unload shares for funds, then BIEL could buy much more time. Something good has to happen very soon or BIEL won't be able to make payroll. I am determined to remain here (regardless of Allay's outcome) and until the outcome of Actipatch, which either will be the end - or the 'beginning' for real success of BIEL. IMO

Thanks fuente; I think we are about half way through the first 30 days, but 30 more days after those first 30 days - with what is happening - could be next to unbearable, but it looks like some who dumped, are starting to buy back?

I don't think that's what I wanted to hear today - but thanks.

Imrich, fuente, ect., Does the FDA typically respond to the appeal within a certain time frame - or is is just like everything else over there? (Since this latest appeal meeting was not a response from the FDA, but a meeting for BIEL to technically back their claims and sway previous decision through the appeal process)....for example, could this drag out for months? How long can they make everyone wait again - then possibly only to reaffirm their previous stance or possibly approve Allay?